cystic-fibrosis

Documents about cystic-fibrosis

• Virtual Reality for the Reduction of Pain During Venipuncture in Children With CF#884621ClinicalTrials.gov
• Novel Therapeutic Approaches for Treatment of CF Patients With W1282X Premature Termination Codon Mutations#1045206ClinicalTrials.gov
• A Study to Compare US Marketed Creon Manufactured With a Modernized Process at an Alternate Manufacturing Site and Manufactured With the Approved Manufacturing Process at an Alternate Active Pharmaceutical Ingredient Site, in Participants With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis#906129ClinicalTrials.gov
• Diabetes Therapy to Improve BMI and Lung Function in CF#67791ClinicalTrials.gov
• A protocol for emulating four published randomised controlled trials using registry data: effects of antibiotics in cystic fibrosis#257901LSHTM Data Compass
• Exploring the lived experiences of individuals with cystic fibrosis after the implementation of elexacaftor/tezacaftor/ivacaftor for treatment.#406398NCBI PubMed Central
• Acceptability, Feasibility and Preliminary Efficacy of CFWP to Treat Clinically Elevated Fatigue in Adults With CF#857944ClinicalTrials.gov
• Study of a Nebulised Nitric Oxide Generating Solution in Patients With Mycobacterium Abscessus#883351ClinicalTrials.gov
• Real-World Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis: A 24-Month Italian National Registry Study.#9130NCBI PubMed Central
• Development and Validation of a Disease Specific PROM to Assess Abdominal Involvement in Patients With CF (CFAbd-Score)#148677ClinicalTrials.gov
• Evolution of body image across treatment eras: a systematic review in young people and adults living with cystic fibrosis.#182262NCBI PubMed Central
• Early inflammatory macrophage reprogramming by Scedosporium apiospermum determines fungal survival#818528HAL (France)
• A Study of Lung Clearance After Hypertonic Saline Delivery Using the tPAD Device#874588ClinicalTrials.gov
• Comparison of the Airway Clearance Efficacy of Electro Flo 5000 and the G5 Flimm-Fighter in Patients With CF#889935ClinicalTrials.gov
• Ivacaftor and symptoms of extra-oesophageal reflux in patients with cystic fibrosis and G551D mutation#954976Koc University Digital Collections
• LBM & Lung Function in Adolescents With CF#1046936ClinicalTrials.gov
• Safety, Efficacy, and Feasibility of High-dose Cholecalciferol in Pediatric Patients With Cystic Fibrosis#1047458ClinicalTrials.gov
• Effects of Training Intensity on Physical Fitness and Body Composition in Cystic Fibrosis#1030929ClinicalTrials.gov
• Navigating Change – UK specialised adult cystic fibrosis service delivery in the highly effective modulator therapy era#130485Unpaywall
• Low-dose nitric oxide as targeted anti-biofilm adjunctive therapy to treat chronic Pseudomonas aeruginosa infection in cystic fibrosis#181120Southampton
• Volatilomic Approaches for the Study of CFTR Modulators (VOLATIL-CF)#857316ClinicalTrials.gov
• Evaluating Bronchodilator Response in Patients With Bronchiectasis#887681ClinicalTrials.gov
• A Prospective Study of Factors Related to Exacerbation and Mortality of Non-cystic Fibrosis Bronchiectasis in Hong Kong#1008429ClinicalTrials.gov
• Identification of DksA as a novel pro-inflammatory mediator of Pseudomonas aeruginosa under conditions mimicking chronic cystic fibrosis lung infection.#182565NCBI PubMed Central
• A DNA Tetrahedron-Delivered miR-17-5p mimic exerts dual anti-inflammatory and Anti-Pseudomonas aeruginosa effects in cystic fibrosis.#440809NCBI PubMed Central
• Assess Increased Mortality Risk With Each Year of Delayed Tobramycin Solution (TIS) Initiation, and Effect of TIS on Mortality Across Study Centers#807046ClinicalTrials.gov
• Tobramycin Inhalation Powder (TIP) Administered Once Daily Continuously Versus TIP Administered BID in 28 Day on / 28 Day Off Cycles#853896ClinicalTrials.gov
• Single Dose of pGM169/GL67A in CF Patients#900890ClinicalTrials.gov
• ACCESS 2: AI for pediatriC diabetiC Eye examS Study 2#991810ClinicalTrials.gov
• Impaired expression of hypoxia-inducible factor-1α in cystic fibrosis airway epithelial cells – A role for HIF-1 in the pathophysiology of CF?#211121HAL (France)
• The prevalence of obstructive sleep apnea-hypopnea syndrome in patients with cystic fibrosis: An updated systematic review and meta-analysismeta-analysis.#388952NCBI PubMed Central
• EASE-CF: dietitian-led weight-loss intervention for adults with cystic fibrosis and excess weight: protocol for a feasibility randomised controlled trial.#409195NCBI PubMed Central
• An Assistive Powered Wheelchair: Stage 2 Trial#879241ClinicalTrials.gov
• The Effects of Discontinuation of Vitamin K Antagonists on the Rate of Elastin Degradation#880416ClinicalTrials.gov
• Efficacy and Safety of 24 Weeks of Oral Treatment With BIIL 284 BS in Adult and Pediatric Patients#902957ClinicalTrials.gov
• Remote Monitoring of High-Risk Patients With Chronic Cardiopulmonary Diseases#910049ClinicalTrials.gov
• Study to Evaluate Lumacaftor and Ivacaftor Combination Therapy in Subjects 12 Years and Older With Advanced Lung Disease#916695ClinicalTrials.gov
• Long Term Nebulised Gentamicin in Patients With Bronchiectasis#1010543ClinicalTrials.gov
• Bacille Calmette-Guerin (BCG) Vaccine for Immune Protection Against Infections#1044182ClinicalTrials.gov
• Role of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) in pathogenesis of Giardia duodenalis infections#257082edoc-Server
• CFTR mutations and genotypic patterns among cystic fibrosis patients with allergic bronchopulmonary aspergillosis: analysis from a tertiary care center in Saudi Arabia.#685739NCBI PubMed Central
• Lum-Iva-biota: Exploring the Respiratory Mycobiota and Microbiota Profile in French CF Patients Taking Lumacaftor-Ivacaftor#828484ClinicalTrials.gov
• Baby Observational and Nutritional Study#841049ClinicalTrials.gov
• Evolution of the 6-minute Walk Test in Patients Treated With ELEXACAFTOR / TEZACAFTOR / IVACAFTOR#894417ClinicalTrials.gov
• Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease#184722ClinicalTrials.gov
• Relação entre alterações funcionais e radiológicas em pacientes com fibrose cística#436492Lume 5.8
• Safety and Feasibility of High-intensity Interval Training Program in CF Patients#855673ClinicalTrials.gov
• The impact of progressive expansion of elexacaftor-tezacaftor-ivacaftor availability on lung transplant for cystic fibrosis in France#122024HAL (France)
• A First in Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled ETD001 in Healthy Subjects#828232ClinicalTrials.gov
• Prevention of CF Exacerbation in Childhood: PREVEC Study#850274ClinicalTrials.gov